A novel platform for nonribosomal peptide discovery
Active Project Grant Awarded Last action
- Award ID
- R44GM159545
- Recipient
-
Chemia Biosciences, Inc. UEI F91YML3Q7YU3
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,549,308
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 44% complete
- Place of performance
- Pittsburgh, PA 15217, USA
Award details come from USAspending.gov.
Description
- Abstract
- Natural products are the major source of drug molecules. Currently, 64% of small molecule drugs approved by the food and drug administration are natural products or their derivatives. Currently, the dominant technique for discovering novel natural products is bioactivity-guided isolation. However, this technique is limited to the high abundance of molecular products of microbial / plant species. Since most of the widely expressed natural products (NPS) have already been picked, bioactivity-guided techniques now lead to high rediscovery rates of known molecules. This proposal focuses on developing a novel platform for discovering natural product small molecules by integrating genome mining with computational metabolomics. With the advent of high throughput tandem mass spectrometry, metabolomics datasets collected on the supernatant of microbial / plant species have become available. However, computational techniques for identifying novel small molecules from these large and complex datasets are in their early stages. Recently, we developed dereplicator, dereplicator+, and moldiscovery to identify known small molecules by searching their tandem mass spectra against public chemical databases such as pubchem. In phase I of this proposal, we developed vinsmoc, a novel mass spectral database search method for the systematic discovery of novel variants of natural product small molecules. The overarching goal of this proposal is to develop natdiscovery, efficient and accurate methods for identifying novel non-ribosomal peptides from complex mass spectral datasets. We will further apply methods developed in this proposal to discover novel non-ribosomal peptides from 1588 actinobacterial strains. Twenty NRP with novel chemistries/enzymes will be isolated and characterized at blumberg institute, and we will screen them for antibacterial, antifungal, and antitumor activities.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $767,806 | |
| Original award | $781,502 |
Quick answers
Who received award R44GM159545?
R44GM159545 was awarded to Chemia Biosciences, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on July 1, 2025.
How much is award R44GM159545 worth?
$1,549,308 has been obligated on R44GM159545.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award